With the outbreak of the COVID-19 pandemic and associated restrictions, patients are unable to seek medical care. To mitigate these challenges, pharmaceutical companies have developed self-administered dosage forms, and more syringe injection molds to simplify the treatment process. In this context, it is worth mentioning that global population growth and a shortage of medical facilities have paved the way for the wider adoption of self-administered dosage forms (such as pre-loaded syringes) among patients.